Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $6.9 million.

  • Molecular Partners Ag's Total Non-Current Liabilities rose 5.73% to $6,099 in Q3 2025 from the same period last year, while for Sep 2025 it was $6,099, marking a year-over-year increase of 5.73%. This contributed to the annual value of $6.9 million for FY2024, which is 82936.46% up from last year.
  • Per Molecular Partners Ag's latest filing, its Total Non-Current Liabilities stood at $6.9 million for FY2024, which was up 82,936.46% from $8,359 recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's Total Non-Current Liabilities peaked at $25.1 million during FY2020, and registered a low of $8,359 during FY2023.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $10,215 (2022), whereas its average is $2.3 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 99.92% in 2021, then surged by 82,936.46% in 2024.
  • Molecular Partners Ag's Total Non-Current Liabilities (Yearly) stood at $25.1 million in 2020, then slumped by 99.92% to $20,078 in 2021, then tumbled by 49.12% to $10,215 in 2022, then fell by 18.17% to $8,359 in 2023, then spiked by 82,936.46% to $6.9 million in 2024.